CoChat
Sign Up
Cited by 180Geomagnetism and Paleomagnetism StudiesMagnetic Properties and Synthesis of FerritesCharacterization and Applications of Magnetic Nanoparticles

The DOI matches its Crossref record.

Applications of Magnetotactic Bacteria, Magnetosomes and Magnetosome Crystals in Biotechnology and Nanotechnology: Mini-Review

Open access
Vargas, Gabriele, Cypriano, Jefferson, Correa, Tarcisio, Leão, Pedro, Bazylinski, Dennis A., Abreu, Fernanda·2018·Molecules
DOI 10.3390/molecules23102438PMC PMC6222368
Open this paper in CoChat — free accountOpen PDF

Abstract

Magnetotactic bacteria (MTB) biomineralize magnetosomes, which are defined as intracellular nanocrystals of the magnetic minerals magnetite (Fe₃O₄) or greigite (Fe₃S₄) enveloped by a phospholipid bilayer membrane. The synthesis of magnetosomes is controlled by a specific set of genes that encode proteins, some of which are exclusively found in the magnetosome membrane in the cell. Over the past several decades, interest in nanoscale technology (nanotechnology) and biotechnology has increased significantly due to the development and establishment of new commercial, medical and scientific processes and applications that utilize nanomaterials, some of which are biologically derived. One excellent example of a biological nanomaterial that is showing great promise for use in a large number of commercial and medical applications are bacterial magnetite magnetosomes. Unlike chemically-synthesized magnetite nanoparticles, magnetosome magnetite crystals are stable single-magnetic domains and are thus permanently magnetic at ambient temperature, are of high chemical purity, and display a narrow size range and consistent crystal morphology. These physical/chemical features are important in their use in biotechnological and other applications. Applications utilizing magnetite-producing MTB, magnetite magnetosomes and/or magnetosome magnetite crystals include and/or involve bioremediation, cell separation, DNA/antigen recovery or detection, drug delivery, enzyme immobilization, magnetic hyperthermia and contrast enhancement of magnetic resonance imaging. Metric analysis using Scopus and Web of Science databases from 2003 to 2018 showed that applied research involving magnetite from MTB in some form has been focused mainly in biomedical applications, particularly in magnetic hyperthermia and drug delivery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules23102438

Cites

Statistics

Figures

Figure 1 Classification of scientific publications reporting on applications of magnetosomes by area [7,8] from 1987 until 2018. Scientific articles containing the keyword “magnetosome (s)” in the title were classified in different subareas of Biotechnology (bioremediation, cell separation, DNA analysis, drug delivery, enzyme immobilization, food, hyperthermia, image contrast). For analysis of raw data, see Table S1. The criteria used for selection of these data are detailed in “Database generation & analysis section”.
Figure 1 Classification of scientific publications reporting on applications of magnetosomes by area [7,8] from 1987 until 2018. Scientific articles containing the keyword “magnetosome (s)” in the title were classified in different subareas of Biotechnology (bioremediation, cell separation, DNA analysis, drug delivery, enzyme immobilization, food, hyperthermia, image contrast). For analysis of raw data, see Table S1. The criteria used for selection of these data are detailed in “Database generation & analysis section”.CC BY · PubMed Central
Figure 2 Global publication records (1st January 1975–25th February 2018) containing the keywords “magnetotactic bacteria or magnetosome(s)” in article titles [7,8]. For analysis of the raw data, see Table S2. The criteria used for selection of data are detailed in the “Database generation & analysis section”.
Figure 2 Global publication records (1st January 1975–25th February 2018) containing the keywords “magnetotactic bacteria or magnetosome(s)” in article titles [7,8]. For analysis of the raw data, see Table S2. The criteria used for selection of data are detailed in the “Database generation & analysis section”.CC BY · PubMed Central
Figure 3 Total number of publications by application area. All scientific articles on databases [7,8] containing the keyword “magnetosome (s)” in article title were classified according to application area in Biotechnology (bioremediation, cell separation, DNA analysis, drug delivery, enzyme immobilization, food, hyperthermia, image contrast). For analysis of raw data, see Table S1. The criteria used for selection of these data are detailed in “Database generation & analysis section”.
Figure 3 Total number of publications by application area. All scientific articles on databases [7,8] containing the keyword “magnetosome (s)” in article title were classified according to application area in Biotechnology (bioremediation, cell separation, DNA analysis, drug delivery, enzyme immobilization, food, hyperthermia, image contrast). For analysis of raw data, see Table S1. The criteria used for selection of these data are detailed in “Database generation & analysis section”.CC BY · PubMed Central
Figure 4 Transmission electron microscopy images of magnetosomes organized in chain(s) within magnetotactic bacteria, showing cuboctahedral (A), prismatic (B) and bullet-shaped (C) magnetite magnetosomes.
Figure 4 Transmission electron microscopy images of magnetosomes organized in chain(s) within magnetotactic bacteria, showing cuboctahedral (A), prismatic (B) and bullet-shaped (C) magnetite magnetosomes.CC BY · PubMed Central
Figure 5 Illustrative scheme of magnetosome purification. Cells of Magnetospirillum gryphiswaldense strain MRS-1 are grown in a fermenter and then lysed using different methods and magnetosomes purified from lysed cells using magnetic concentration and separation. This scheme is based on numerous studies [12,56,60,61,62,63,64].
Figure 5 Illustrative scheme of magnetosome purification. Cells of Magnetospirillum gryphiswaldense strain MRS-1 are grown in a fermenter and then lysed using different methods and magnetosomes purified from lysed cells using magnetic concentration and separation. This scheme is based on numerous studies [12,56,60,61,62,63,64].CC BY · PubMed Central
Figure 6 Illustrative scheme showing the magnetic recovery of Se-containing cells of Ms. magneticum strain AMB-1 grown in culture medium containing SeO32−. Cells reduced SeO32− to Se which accumulated in cells as intracytoplasmic granules (green). After seven days of incubation followed by magnetic separation of the cells, 68.1% of the Se was removed from the medium [85].
Figure 6 Illustrative scheme showing the magnetic recovery of Se-containing cells of Ms. magneticum strain AMB-1 grown in culture medium containing SeO32−. Cells reduced SeO32− to Se which accumulated in cells as intracytoplasmic granules (green). After seven days of incubation followed by magnetic separation of the cells, 68.1% of the Se was removed from the medium [85].CC BY · PubMed Central
Figure 7 Illustrative scheme of the functionalization of magnetosome from Ms. gryphyswaldense strain MSR-1 with doxorubicin (DOX) binding to the amino groups of magnetosome proteins (red rectangles) inserted into the membrane of magnetosomes, forming DBM (DOX loaded magnetosomes). After treatment with DBM, cancer cells were inhibited from growing and the use of DBM resulted in a slow release of DOX. This indicates that the DBM complex is not degraded during systemic circulation and possesses potent antitumor activity [63].
Figure 7 Illustrative scheme of the functionalization of magnetosome from Ms. gryphyswaldense strain MSR-1 with doxorubicin (DOX) binding to the amino groups of magnetosome proteins (red rectangles) inserted into the membrane of magnetosomes, forming DBM (DOX loaded magnetosomes). After treatment with DBM, cancer cells were inhibited from growing and the use of DBM resulted in a slow release of DOX. This indicates that the DBM complex is not degraded during systemic circulation and possesses potent antitumor activity [63].CC BY · PubMed Central
Figure 8 Illustrative scheme of cancer hyperthermia therapy research protocols using magnetosome magnetite crystals [104]. Magnetosomes coated with poly-l-lysine (PLL) without membrane (M-PLL) presented an antitumor effect in intracranial U87-Luc tumors in mice. This effect was observed after treatment of mice with 500 μg of M-PLL followed by 28 magnetic sessions (MS) 30 min/day with 202 kHz and 27 mT. In this case, hyperthermia induced a temperature increase, reaching 42 °C. After 350 days of the first exposure, tumors were eliminated in 100% of the treated mice. In contrast, the same treatment using superparamagnetic iron oxide nanoparticles (SION) resulted in a less effective increase of temperature and only 20% mice had tumors eliminated after 350 days [100].
Figure 8 Illustrative scheme of cancer hyperthermia therapy research protocols using magnetosome magnetite crystals [104]. Magnetosomes coated with poly-l-lysine (PLL) without membrane (M-PLL) presented an antitumor effect in intracranial U87-Luc tumors in mice. This effect was observed after treatment of mice with 500 μg of M-PLL followed by 28 magnetic sessions (MS) 30 min/day with 202 kHz and 27 mT. In this case, hyperthermia induced a temperature increase, reaching 42 °C. After 350 days of the first exposure, tumors were eliminated in 100% of the treated mice. In contrast, the same treatment using superparamagnetic iron oxide nanoparticles (SION) resulted in a less effective increase of temperature and only 20% mice had tumors eliminated after 350 days [100].CC BY · PubMed Central
Figure 9 Schematic representation of a functionalized magnetosome according to each application described in the Biotechnology section of this review (cell separation; hyperthermia, drug delivery, image contrast, food analysis, enzyme immobilization and bioremediation and DNA and antigen recovery/detection). Drug delivery: the association between the surface proteins of the magnetosome and doxorubicin (DOX), an anti-breast cancer drug [63]. Cell separation: the modified magnetosomes were bound to anti-murinic G Ig anti-CD19 and used for separating B-lymphocytes from peripheral blood cells [90]. Food sciences: a capture system with the magnetosome proteins fused using a cross-linking reagent bis(sulfosuccinimidyl) suberate (BS3) for attachment of antibodies to Salmonella and Vibrio species from food samples (e.g., milk, egg and pork) [76]. DNA/Antigen analysis: antibody-functionalized magnetosomes were used for immobilization of HBsAg (hepatitis B antigen) in human serum and enhancement of sensitivity of immunoassay [72]. Image contrast: magnetosomes with specific proteins bound to the surface with high affinity to target cells were used as superparamagnetic contrast agents for magnetic resonance imaging [117]. Hyperthermia: magnetosomes coated with poly-l-lysine (PLL) were used in hyperthermia [100]. Enzyme immobilization and bioremediation: magnetosome expressing MamC fused with organophosphohydrolase (OPD) from of Flavobacterium sp., were used for the degradation of paraoxon [103].
Figure 9 Schematic representation of a functionalized magnetosome according to each application described in the Biotechnology section of this review (cell separation; hyperthermia, drug delivery, image contrast, food analysis, enzyme immobilization and bioremediation and DNA and antigen recovery/detection). Drug delivery: the association between the surface proteins of the magnetosome and doxorubicin (DOX), an anti-breast cancer drug [63]. Cell separation: the modified magnetosomes were bound to anti-murinic G Ig anti-CD19 and used for separating B-lymphocytes from peripheral blood cells [90]. Food sciences: a capture system with the magnetosome proteins fused using a cross-linking reagent bis(sulfosuccinimidyl) suberate (BS3) for attachment of antibodies to Salmonella and Vibrio species from food samples (e.g., milk, egg and pork) [76]. DNA/Antigen analysis: antibody-functionalized magnetosomes were used for immobilization of HBsAg (hepatitis B antigen) in human serum and enhancement of sensitivity of immunoassay [72]. Image contrast: magnetosomes with specific proteins bound to the surface with high affinity to target cells were used as superparamagnetic contrast agents for magnetic resonance imaging [117]. Hyperthermia: magnetosomes coated with poly-l-lysine (PLL) were used in hyperthermia [100]. Enzyme immobilization and bioremediation: magnetosome expressing MamC fused with organophosphohydrolase (OPD) from of Flavobacterium sp., were used for the degradation of paraoxon [103].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 131

  1. Bazylinski, 2004, Magnetosome formation in prokaryotes, Nat. Rev. Microbiol., 2, 217, 10.1038/nrmicro842 · DOI
  2. Frankel, 2006, How magnetotactic bacteria make magnetosomes queue up, Trends Microbiol., 14, 329, 10.1016/j.tim.2006.06.004 · DOI
  3. Bellini, 2009, Ulteriori Studi Sui “batteri Magnetosensibili”. Universita di Pavia, Pavia, Italy, 1963, apud Frankel, R.B. The discovery of magnetotactic/magnetosensitive bactéria, Chin. J. Oceanol. Limnol., 27, 1
  4. Blakemore, 1975, Magnetotactic bacteria, Science, 190, 377, 10.1126/science.170679 · DOI
  5. Lower, 2013, The bacterial magnetosome: A unique prokaryotic organelle, J. Mol. Microbiol. Biotechnol., 23, 63
  6. Lefevre, 2013, Ecology, diversity, and evolution of magnetotactic bacteria, Microbiol. Mol. Biol. Rev., 77, 497, 10.1128/MMBR.00021-13 · DOI
  7. Scopus (2018). Elsevier′s scopus, the largest abstract and citation database of peer-reviewed literature. Elsevier′s Scopus, Elsevier. Available online: https://www.scopus.com/.
  8. Yan, 2017, Bacterial magnetosome and its potential application, Microbiol. Res., 203, 19, 10.1016/j.micres.2017.06.005 · DOI
  9. Jacob, 2016, Magnetotactic bacteria and magnetosomes - scope and challenges, Mater. Sci. Eng. C Mater. Biol. Appl., 68, 919, 10.1016/j.msec.2016.07.049 · DOI
  10. Matsunaga, 1987, Use of magnetic particles isolated from magnetotactic bacteria for enzyme immobilization, Appl. Microbiol. Biotechnol., 26, 328, 10.1007/BF00256663 · DOI
  11. Gorby, 1988, Characterization of the bacterial magnetosome membrane, J. Bacteriol., 170, 834, 10.1128/jb.170.2.834-841.1988 · DOI
  12. Faivre, 2008, Magnetotactic bacteria and magnetosomes, Chem. Rev., 108, 4875, 10.1021/cr078258w · DOI
  13. Murat, 2010, Cell biology of prokaryotic organelles, Cold Spring Harb. Perspect. Biol., 2, a000422, 10.1101/cshperspect.a000422 · DOI
  14. Abreu, 2013, Cell adhesion, multicellular morphology, and magnetosome distribution in the multicellular magnetotactic prokaryote Candidatus Magnetoglobus multicellularis, Microsc. Microanal., 19, 535, 10.1017/S1431927613000329 · DOI
  15. Komeili, 2012, Molecular mechanisms of compartmentalization and biomineralization in magnetotactic bacteria, FEMS Microbiol. Rev., 36, 232, 10.1111/j.1574-6976.2011.00315.x · DOI
  16. Kundu, 2009, On the change in bacterial size and magnetosome features for Magnetospirillum magnetotacticum (MS-1) under high concentrations of zinc and nickel, Biomaterials, 30, 4211, 10.1016/j.biomaterials.2009.04.039 · DOI
  17. Otto, 2004, Biochemical and proteomic analysis of the magnetosome membrane in Magnetospirillum gryphiswaldense, Appl. Environ. Microbiol., 70, 1040, 10.1128/AEM.70.2.1040-1050.2004 · DOI
  18. Amemiya, 2007, Controlled formation of magnetite crystal by partial oxidation of ferrous hydroxide in the presence of recombinant magnetotactic bacterial protein Mms6, Biomaterials, 28, 5381, 10.1016/j.biomaterials.2007.07.051 · DOI
  19. Arakaki, 2003, A novel protein tightly bound to bacterial magnetic particles in Magnetospirillum magneticum strain AMB-1, J. Biol. Chem., 278, 8745, 10.1074/jbc.M211729200 · DOI
  20. Murat, 2010, Comprehensive genetic dissection of the magnetosome gene island reveals the step-wise assembly of a prokaryotic organelle, Proc. Natl. Acad. Sci. USA, 107, 5593, 10.1073/pnas.0914439107 · DOI
  21. Quinlan, 2011, The htra/degp family protease mame is a bifunctional protein with roles in magnetosome protein localization and magnetite biomineralization, Mol. Microbiol., 80, 1075, 10.1111/j.1365-2958.2011.07631.x · DOI
  22. Scheffel, 2008, The major magnetosome proteins mamgfdc are not essential for magnetite biomineralization in Magnetospirillum gryphiswaldense but regulate the size of magnetosome crystals, J. Bacteriol., 190, 377, 10.1128/JB.01371-07 · DOI
  23. Tanaka, 2006, Origin of magnetosome membrane: Proteomic analysis of magnetosome membrane and comparison with cytoplasmic membrane, Proteomics, 6, 5234, 10.1002/pmic.200500887 · DOI
  24. Faivre, 2015, From bacteria to mollusks: The principles underlying the biomineralization of iron oxide materials, Angew. Chem. Int. Ed., 54, 4728, 10.1002/anie.201408900 · DOI
  25. DeLong, E.F., Lory, S., Stackebrandt, E., and Thompson, F. (2013). Magnetotactic Bacteria. The Prokaryotes, Springer.
  26. Baumgartner, 2013, Magnetotactic bacteria form magnetite from a phosphate-rich ferric hydroxide via nanometric ferric (oxyhydr) oxide intermediates, Proc. Natl. Acad. Sci. USA, 110, 883, 10.1073/pnas.1307119110 · DOI
  27. Buseck, 1998, Iron sulfides from magnetotactic bacteria: Structure, composition, and phase transitions, Am. Mineral., 83, 1469, 10.2138/am-1998-11-1235 · DOI
  28. Li, 2010, Magnetite nanoparticles with high heating efficiencies for application in the hyperthermia of cancer, Mater. Sci Eng., 30, 990, 10.1016/j.msec.2010.04.016 · DOI
  29. Sun, 2002, Size-Controlled Synthesis of Magnetite Nanoparticles, J. Am. Chem. Soc., 124, 8204, 10.1021/ja026501x · DOI
  30. Schwab, 2004, Polymeric precursors to refractory metal borides, J. Mat. Sci., 39, 6051, 10.1023/B:JMSC.0000041701.01103.41 · DOI
  31. Qi, 2011, A non-alkoxide sol-gel method for the preparation of magnetite (Fe3O4) nanoparticles, Curr. Nanosci., 7, 381, 10.2174/157341311795542426 · DOI
  32. Wang, 2010, Shape-control and characterization of magnetite prepared via a one-step solvothermal route, Cryst. Growth Des., 10, 2863, 10.1021/cg900472d · DOI
  33. Peigneux, 2016, Learning from magnetotactic bacteria: A review on the synthesis of biomimetic nanoparticles mediated by magnetosome-associated proteins, J. Struct. Biol., 196, 75, 10.1016/j.jsb.2016.06.026 · DOI · Paper page
  34. 2014, Applications of magnetosomes synthesized by magnetotactic bacteria in medicine, Front. Bioen. Biotechnol., 2, 5
  35. Bazylinski, 1995, Controlled biomineralization of magnetite Fe3O4 and greigite Fe3O4 in a magnetotactic bacterium, Appl. Environ. Microbiol., 61, 3232, 10.1128/aem.61.9.3232-3239.1995 · DOI
  36. Bazylinski, 1994, Electron microscopic studies of magnetosomes in magnetotactic bacteria, Microsc. Res. Tech., 27, 389, 10.1002/jemt.1070270505 · DOI
  37. Balkwill, 1980, Ultra-structure of a magnetotactic spirillum, J. Bacteriol., 141, 1399, 10.1128/jb.141.3.1399-1408.1980 · DOI
  38. Mann, 1984, Structure, morphology and crystal growth of bacterial magnetite, Nature, 310, 405, 10.1038/310405a0 · DOI
  39. Mann, 1984, A high resolution electron microscopic investigation of bacterial magnetite. Implications for crystal growth, Proc. R. Soc. Lond. B., 310, 385
  40. Kiseleva, 2015, Magnet-facilitated selection of electrogenic bacteria from marine sediment, Biomed. Res. Int., 2015, 582471, 10.1155/2015/582471 · DOI
  41. Frankel, 2011, Culture-independent characterization of a novel, uncultivated magnetotactic member of the nitrospirae phylum, Environ. Microbiol., 13, 538, 10.1111/j.1462-2920.2010.02361.x · DOI
  42. Li, 2015, Crystal growth of bullet-shaped magnetite in magnetotactic bacteria of the nitrospirae phylum, J. R Soc. Interface, 12, 20141288, 10.1098/rsif.2014.1288 · DOI
  43. Mann, 1988, Ultrastructure, morphology and organization of biogenic magnetite from sockeye salmon, oncorhynchus nerka: Implications for magnetoreception, J. Exp. Biol., 140, 35, 10.1242/jeb.140.1.35 · DOI
  44. Lovely, D.R. (2000). Biologically controlled mineralization of magnetic iron minerals by MTB. Environmental Microbe-Mineral Interactions, ASM Press. · DOI
  45. Baeuerlein, E. (2000). Magnetic iron oxide and iron sulfide minerals within organisms. Biomineralization: From Biology to Biotechnology and Medical Application, Wiley-VCH.
  46. Lins, 2005, Habits of magnetosome crystals in coccoid magnetotactic bacteria, Appl. Environ. Microbiol., 71, 4902, 10.1128/AEM.71.8.4902-4905.2005 · DOI
  47. Spring, 1998, Phylogenetic affiliation and ultrastructure of uncultured magnetic bacteria with unusually large magnetosomes, Arch. Microbiol., 169, 136, 10.1007/s002030050553 · DOI
  48. Albrecht, 2005, Scanning force microspy study of biogenic nanoparticles for medical applications, J. Magn. Magn. Mater., 290–291, 269, 10.1016/j.jmmm.2004.11.206 · DOI
  49. Butler, 1975, Theoretical single-domain grain size range in magnetite and titanomagnetite, J. Geophysics, 80, 4049, 10.1029/JB080i029p04049 · DOI
  50. Frankel, 1980, Navigational compass in magnetic bacteria, J. Magn. Magn. Mater, 1562, 15
  51. Moskowitz, 1995, Biomineralization of magnetic minerals, Rev. Geophys., 33, 123, 10.1029/95RG00443 · DOI
  52. Feng, 2013, Bioinspired Greigite Magnetic Nanocrystals: Chemical Synthesis and Biomedicine Applications, Sci. Rep., 3, 2994, 10.1038/srep02994 · DOI
  53. Xie, 2009, Production, modification and bio-applications of magnetic nanoparticles gestated by magnetotactic bacteria, Nano Res., 2, 261, 10.1007/s12274-009-9025-8 · DOI
  54. Yan, 2012, Magnetotactic bacteria, magnetosomes and their application, Microbiol. Res., 167, 507, 10.1016/j.micres.2012.04.002 · DOI
  55. Heyen, 2003, Growth and magnetosome formation by microaerophilic Magnetospirillum strains in an oxygen-controlled fermentor, Appl. Microbiol. Biotechnol., 61, 536, 10.1007/s00253-002-1219-x · DOI
  56. Xu, 2014, Bio and nanomaterials based on Fe3O4, Molecules, 19, 21506, 10.3390/molecules191221506 · DOI
  57. Liu, 2010, Large-scale production of magnetosomes by chemostat culture of Magnetospirillum gryphiswaldense at high cell density, Microb. Cell. Fact., 9, 99, 10.1186/1475-2859-9-99 · DOI
  58. Zhang, 2011, Semicontinuous culture of Magnetospirillum gryphiswaldense MSR-1 cells in an autofermentor by nutrient-balanced and isosmotic feeding strategies, Appl. Environ. Microbiol., 77, 5851, 10.1128/AEM.05962-11 · DOI
  59. Sun, 2008, High-yield growth and magnetosome formation by Magnetospirillum gryphiswaldense MSR-1 in an oxygen-controlled fermentor supplied solely with air, Appl. Microbiol. Biotechnol., 79, 389, 10.1007/s00253-008-1453-y · DOI
  60. Araujo, 2015, Magnetotactic bacteria as potential sources of bioproducts, Mar. Drugs, 13, 389, 10.3390/md13010389 · DOI
  61. Xiang, 2007, Purified and sterilized magnetosomes from Magnetospirillum gryphiswaldense MSR-1 were not toxic to mouse fibroblasts in vitro, Lett. Appl. Microbiol., 45, 75, 10.1111/j.1472-765X.2007.02143.x · DOI
  62. Sun, 2008, Preparation and anti-tumor efficiency evaluation of doxorubicin-loaded bacterial magnetosomes: Magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense, Biotechnol. Bioeng., 101, 1313, 10.1002/bit.22011 · DOI
  63. Amor, 2015, Chemical signature of magnetotactic bacteria, Proc. Natl. Acad. Sci. USA, 112, 1699, 10.1073/pnas.1414112112 · DOI
  64. Sun, 2011, Bacterial magnetosome: A novel biogenetic magnetic targeted drug carrier with potential multifunctions, J. Nanomater, 2011, 469031, 10.1155/2011/469031 · DOI
  65. Yoshino, 2005, Development of efficient expression system for protein display on bacterial magnetic particles, Biochem. Biophys. Res. Commun., 338, 1678, 10.1016/j.bbrc.2005.10.148 · DOI
  66. Kuhara, 2004, Magnetic cell separation using antibody binding with protein a expressed on bacterial magnetic particles, Anal. Chem., 76, 6207, 10.1021/ac0493727 · DOI
  67. Tanaka, 2000, Fully automated chemiluminescence immunoassay of insulin using antibody-Protein A–Bacterial magnetic particle complexes, Anal. Chem., 72, 3518, 10.1021/ac9912505 · DOI
  68. Schultheiss, 2003, Development of a genetic system for Magnetospirillum gryphiswaldense, Arch. Microbiol., 179, 89, 10.1007/s00203-002-0498-z · DOI
  69. Mickoleit, 2018, In vivo coating of bacterial magnetic nanoparticles by magnetosome expression of spider silk-inspired peptides, Biomacromolecules, 19, 962, 10.1021/acs.biomac.7b01749 · DOI
  70. Ceyhan, 2006, Semisynthetic biogenic magnetosome nanoparticles for the detection of proteins and nucleic acids, Small, 2, 1251, 10.1002/smll.200600282 · DOI
  71. Wacker, 2007, Magneto immuno-PCR: A novel immunoassay based on biogenic magnetosome nanoparticles, Biochem. Biophys. Res. Commun., 357, 391, 10.1016/j.bbrc.2007.03.156 · DOI
  72. Liu, 2015, Preparation and in vitro antitumor effects of cytosine arabinoside-loaded genipin-poly-l-glutamic acid-modified bacterial magnetosomes, Int. J. Nanomed., 10, 1387, 10.2147/IJN.S76123 · DOI
  73. Cheng, 2016, Co-delivery of doxorubicin and recombinant plasmid phsp70-plk1-shrna by bacterial magnetosomes for osteosarcoma therapy, Int. J. Nanomed., 11, 5277, 10.2147/IJN.S115364 · DOI
  74. Guan, 2015, Ganglioside-magnetosome complex formation enhances uptake of gangliosides by cells, Int. J. Nanomed., 10, 6919
  75. Li, 2010, Rapid separation and immunoassay for low levels of Salmonella in foods using magnetosome-antibody complex and real-time fluorescence quantitative pcr, J. Sep. Sci., 33, 3437, 10.1002/jssc.201000441 · DOI
  76. Wu, 2013, A novel electrochemical immunosensor based on magnetosomes for detection of Staphylococcal enterotoxin B in milk, Talanta, 106, 360, 10.1016/j.talanta.2012.12.053 · DOI
  77. Felfoul, 2016, Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions, Nat. Nanotechnol., 11, 941, 10.1038/nnano.2016.137 · DOI
  78. Shimoshige, H., Nakajima, Y., Kobayashi, H., Yanagisawa, K., Nagaoka, Y., Shimamura, S., Mizuki, T., Inoue, A., and Maekawa, T. (2017). Formation of core-shell nanoparticles composed of magnetite and samarium oxide in Magnetospirillum magneticum strain RSS-1. PLoS ONE, 12. · DOI
  79. Zhou, 2017, Genetic improvement of Magnetospirillum gryphiswaldense for enhanced biological removal of phosphate, Biotechnol. Lett., 39, 1509, 10.1007/s10529-017-2383-5 · DOI
  80. Tanaka, 2012, Highest levels of Cu, Mn and Co doped into nanomagnetic magnetosomes through optimized biomineralisation, J. Mater. Chem., 22, 11919, 10.1039/c2jm31520c · DOI
  81. Prozorov, 2007, Cobalt ferrite nanocrystals: Out-performing magnetotactic bacteria, ACS Nano, 1, 228, 10.1021/nn700194h · DOI
  82. Staniland, 2008, Controlled cobalt doping of magnetosomes in vivo, Nat. Nanotechnol., 3, 158, 10.1038/nnano.2008.35 · DOI
  83. Tanaka, 2010, Simultaneously discrete biomineralization of magnetite and tellurium nanocrystals in magnetotactic bacteria, Appl. Environ. Microbiol., 76, 5526, 10.1128/AEM.00589-10 · DOI
  84. Tanaka, 2016, Biomagnetic recovery and bioaccumulation of selenium granules in magnetotactic bacteria, Appl. Environ. Microbiol., 82, 3886, 10.1128/AEM.00508-16 · DOI
  85. Ali, 2018, An overview of heavy metal removal from wastewater using magnetotactic bacteria, J. Chem. Technol. Biotechnol., 93, 2817, 10.1002/jctb.5648 · DOI
  86. Arakaki, 2002, Cadmium recovery by a sulfate-reducing magnetotactic bacterium, Desulfovibrio magneticus RS-1, using magnetic separation, Appl. Biochem. Biotechnol., 98–100, 833, 10.1385/ABAB:98-100:1-9:833 · DOI
  87. Smit, 2018, Magnetotactic bacteria used to generate electricity based on faraday′s law of electromagnetic induction, Lett. Appl. Microbiol., 66, 362, 10.1111/lam.12862 · DOI
  88. Long, R., Liu, Y., Dai, Q., Wang, S., Deng, Q., and Zhou, X. (2016). A natural bacterium-produced membrane-bound nanocarrier for drug combination therapy. Materials, 9. · DOI
  89. Wang, 2018, An enhanced anti-tumor effect of apoptin-cecropin b on human hepatoma cells by using bacterial magnetic particle gene delivery system, Biochem. Biophys. Res. Commun., 496, 719, 10.1016/j.bbrc.2018.01.108 · DOI
  90. Yoshino, 2008, Magnetic cell separation using nano-sized bacterial magnetic particles with reconstructed magnetosome membrane, Biotechnol. Bioeng., 101, 470, 10.1002/bit.21912 · DOI
  91. Takahashi, 2010, Surface modification of magnetic nanoparticles using asparagines-serine polypeptide designed to control interactions with cell surfaces, Biomaterials, 31, 4952, 10.1016/j.biomaterials.2010.02.048 · DOI
  92. Grouzdev, D.S., Dziuba, M.V., Kurek, D.V., Ovchinnikov, A.I., Zhigalova, N.A., Kuznetsov, B.B., and Skryabin, K.G. (2014). Optimized method for preparation of igg-binding bacterial magnetic nanoparticles. PLoS ONE, 9. · DOI
  93. Xu, 2014, Surface expression of protein a on magnetosomes and capture of pathogenic bacteria by magnetosome/antibody complexes, Front. Microbiol., 5, 136, 10.3389/fmicb.2014.00136 · DOI
  94. Lee, 2011, Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets, Proc. Natl. Acad. Sci. USA, 108, 2662, 10.1073/pnas.1016409108 · DOI
  95. Orlando, 2016, Characterization of magnetic nanoparticles from Magnetospirillum gryphiswaldense as potential theranostics tools, Contrast Media Mol Imaging, 11, 139, 10.1002/cmmi.1673 · DOI
  96. Boucher, 2017, Genetically tailored magnetosomes used as MRI probe for molecular imaging of brain tumor, Biomaterials, 121, 167, 10.1016/j.biomaterials.2016.12.013 · DOI
  97. Goldhawk, D.E., Neil Gelman, T.R.T., and Prato, F.S. (2017). Forming magnetosome-like nanoparticles in mammalian cells for molecular MRI. Design and Applications of Nanoparticles in Biomedical Imaging, Springer International Publishing. · DOI
  98. Xiang, 2017, Tumor detection using magnetosome nanoparticles functionalized with a newly screened egfr/her2 targeting peptide, Biomaterials, 115, 53, 10.1016/j.biomaterials.2016.11.022 · DOI
  99. Idbaih, 2017, Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-luc glioblastoma in 100% of treated mice using magnetic hyperthermia, Biomaterials, 141, 210, 10.1016/j.biomaterials.2017.06.026 · DOI
  100. Faure, 2011, Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy, ACS Nano, 5, 6279, 10.1021/nn201290k · DOI
  101. Mannucci, 2018, Magnetosomes extracted from Magnetospirillum gryphiswaldense as theranostic agents in an experimental model of glioblastoma, Contrast Media Mol. Imaging, 2018, 2198703, 10.1155/2018/2198703 · DOI
  102. Ginet, N., Pardoux, R., Adryanczyk, G., Garcia, D., Brutesco, C., and Pignol, D. (2011). Single-step production of a recyclable nanobiocatalyst for organophosphate pesticides biodegradation using functionalized bacterial magnetosomes. PLoS ONE, 6. · DOI
  103. Honda, 2015, Stoichiometrically controlled immobilization of multiple enzymes on magnetic nanoparticles by the magnetosome display system for efficient cellulose hydrolysis, Biomacromolecules, 16, 3863, 10.1021/acs.biomac.5b01174 · DOI
  104. Martel, 2017, Targeting active cancer cells with smart bullets, Ther. Deliv., 8, 301, 10.4155/tde-2016-0088 · DOI
  105. Takeuchi, 1999, Differential roles of tlr2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components, Immunity, 11, 443, 10.1016/S1074-7613(00)80119-3 · DOI
  106. Weinbaum, 1971, Isolation and chemical and immunological characterization of bacterial lipopolysaccharides, Microbial Toxins, Volume 4, 145
  107. Wang, 2010, Endotoxins: Lipopolysaccharides of gram-negative bacteria, Subcell. Biochem., 53, 3, 10.1007/978-90-481-9078-2_1 · DOI
  108. Tanaka, 2008, Development of a cell surface display system in a magnetotactic bacterium, “Magnetospirillum magneticum” AMB-1, Appl. Environ. Microbiol., 74, 3342, 10.1128/AEM.02276-07 · DOI
  109. Blondeau, 2018, Magnetic-field induced rotation of magnetosome chains in silicified magnetotactic bacteria, Sci. Rep., 8, 7699, 10.1038/s41598-018-25972-x · DOI
  110. Pierce, 2017, Tuning bacterial hydrodynamics with magnetic fields, Phys. Rev. E, 95, 062612, 10.1103/PhysRevE.95.062612 · DOI
  111. Sun, 2007, In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: The magnetic bio-nanoparticles as drug carriers, Cancer Lett., 258, 109, 10.1016/j.canlet.2007.08.018 · DOI
  112. Liu, 2015, The preparation and characterization of micelles from poly (γ-glutamic acid)-graft-poly(l-lactide) and the cellular uptake thereof, J. Mater. Sci. Mater. Med., 26, 187, 10.1007/s10856-015-5519-y · DOI
  113. Matsunaga, T., and Kamiya, S. (1987, January 27–30). Indroduction of bacterial magnetic particles into red blood cells with cell fusion. Proceedings of the 6th International Conference on Biomagnetisms, Toyko, Japan.
  114. Matsunaga, 1989, Phagocytosis of bacterial magnetite by leucocytes, Appl. Microbiol. Biotechnol., 31, 401, 10.1007/BF00257612 · DOI
  115. Herborn, 2003, Magnetosomes as biological model for iron binding: Relaxivity determination with MRI, RoFo, 175, 830
  116. Boucher, 2015, Magnetosomes, biogenic magnetic nanomaterials for brain molecular imaging with 17.2 t MRI scanner, Adv. Healthc. Mater., 4, 1076, 10.1002/adhm.201400756 · DOI
  117. Kraupner, 2017, Bacterial magnetosomes - nature’s powerful contribution to mpi tracer research, Nanoscale, 9, 5788, 10.1039/C7NR01530E · DOI
  118. Gilchrist, 1957, Selective inductive heating of lymph nodes, Ann. Surg., 146, 596, 10.1097/00000658-195710000-00007 · DOI
  119. Moroz, 2002, Magnetically mediated hyperthermia: Current status and future directions, Int. J. Hyperthermia, 18, 267, 10.1080/02656730110108785 · DOI
  120. Idbaih, 2017, Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-luc glioma in mice under the application of an alternating magnetic field, J. Control. Release, 262, 259, 10.1016/j.jconrel.2017.07.020 · DOI
  121. Lee, 2015, Natural magnetic nanoparticle containing droplet for smart drug delivery and heat treatment, Conf. Proc. IEEE Eng. Med. Biol. Soc., 2015, 3541
  122. Mathuriya, 2016, Magnetotactic bacteria: Nanodrivers of the future, Crit. Rev. Biotechnol., 36, 788, 10.3109/07388551.2015.1046810 · DOI
  123. Chebbi, 2013, Use of bacterial magnetosomes in the magnetic hyperthermia treatment of tumours: A review, Int. J. Hyperthermia, 29, 801, 10.3109/02656736.2013.821527 · DOI
  124. Guyot, 2012, Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia, Int. J. Pharm., 434, 444, 10.1016/j.ijpharm.2012.06.015 · DOI
  125. Yoshino, 2018, Biosynthesis of thermoresponsive magnetic nanoparticles by magnetosome display system, Bioconjug. Chem., 29, 1756, 10.1021/acs.bioconjchem.8b00195 · DOI
  126. Hergt, 2005, Magnetic properties of bacterial magnetosomes as potential diagnostic and therapeutic tools, J. Magn. Magn. Mater., 293, 80, 10.1016/j.jmmm.2005.01.047 · DOI
  127. Alphandery, 2018, Fluorescent magnetosomes for controlled and repetitive drug release under the application of an alternating magnetic field under conditions of limited temperature increase (<2.5 °C), Nanoscale, 10, 10918, 10.1039/C8NR02164C · DOI
  128. Preveral, 2018, Targeted thermal therapy with genetically engineered magnetite magnetosomes@RGD: Photothermia is far more efficient than magnetic hyperthermia, J. Control. Release, 279, 271, 10.1016/j.jconrel.2018.04.036 · DOI
  129. Johnson, 2011, Enzyme nanoparticle fabrication: Magnetic nanoparticle synthesis and enzyme immobilization, Methods Mol. Biol., 679, 183, 10.1007/978-1-60761-895-9_15 · DOI
  130. Kolinko, 2014, Biosynthesis of magnetic nanostructures in a foreign organism by transfer of bacterial magnetosome gene clusters, Nat. Nanotechnol., 9, 193, 10.1038/nnano.2014.13 · DOI
  131. Ke, 2017, In situ synthesis of fluorescent magnetosomes using an organic membrane as a soft template, Nanoscale, 9, 5408, 10.1039/C7NR00542C · DOI

Cited by

Sorted by citations

See all 180

Metadata

Authors
Vargas, G., Cypriano, J., Correa, T., Leão, P., Bazylinski, D. A., & Abreu, F.
Affiliations
  • Universidade Federal do Rio de Janeiro (BR)
  • Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho, 373, CCS, UFRJ, Rio de Janeiro, RJ 21941-902, Brazil
  • University of Nevada, Las Vegas (US)
Corresponding author
Abreu, Fernanda
ORCID
Venue
Molecules
Publisher
MDPI AG
Published
2018-09-24
Volume
23
Issue
10
Pages
2438
ISSN
1420-3049 (ISSN-L)
DOI
10.3390/molecules23102438
PMC
PMC6222368
OpenAlex
W2890606087
Cited by
180
References
0
Citations by year
2026: 16 · 2025: 21 · 2024: 15 · 2023: 26 · 2022: 29 · 2021: 35 · 2020: 32 · 2019: 5 · 2018: 1
FWCI
1.79
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Scholarship - UNLV (University of Nevada Reno) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Science Foundation (EAR-1423939)
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (233179, E_26/200.019/2017)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (E_26/200.019/2017)
Topics
  • Physical Sciences › Earth and Planetary Sciences › Geophysics › Geomagnetism and Paleomagnetism Studies
  • Physical Sciences › Materials Science › Materials Chemistry › Magnetic Properties and Synthesis of Ferrites
  • Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
Keywords
magnetotactic bacteria, magnetosomes, magnetite, greigite, biomineralization, magnetic nanoparticles, magnetic hyperthermia, drug delivery, bioremediation, cell isolation, DNA recovery, enzyme immobilization, MRI contrast enhancement
MeSH terms
Bacteria, Bacterial Proteins, Biotechnology, Iron, Sulfides, Ferrosoferric Oxide, Nanoparticles, Magnetosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Applications of Magnetotactic Bacteria, Magnetosomes and Magnetosome Crystals in Biotechnology and Nanotechnology: Mini-Review. https://app.cochat.ai/papers/10.3390/molecules23102438
The paper
Vargas, G., Cypriano, J., Correa, T., Leão, P., Bazylinski, D. A., & Abreu, F. (2018). Applications of Magnetotactic Bacteria, Magnetosomes and Magnetosome Crystals in Biotechnology and Nanotechnology: Mini-Review. Molecules. https://doi.org/10.3390/molecules23102438